Clinical Trial Update: Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine [Phase 2]

View source ↗

Summary

Phase 2 adaptive platform trial evaluating fluoxetine as Intervention A for post-traumatic stress disorder. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Global Coalition for Adaptive Research | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: RECRUITING